
Novel Expanded Safe Zone for Reduction of Submental Fullness with ATX-101 Injection
Author(s) -
Sachin M. Shridharani,
Akash Chandawarkar
Publication year - 2019
Publication title -
plastic and reconstructive surgery/psef cd journals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.841
H-Index - 179
eISSN - 1076-5751
pISSN - 0032-1052
DOI - 10.1097/prs.0000000000006299
Subject(s) - medicine , adverse effect , surgery , reduction (mathematics) , subcutaneous fat , adipose tissue , geometry , mathematics
ATX-101 (deoxycholic acid injection; Kybella) provides an approved nonsurgical treatment option for reduction of submental fullness caused by submental fat. Current one-size-fits-all recommendations for the use of ATX-101 limit treatment to a central area, which may not provide complete resolution of submental fat for some patients. An expanded safe zone is described, allowing for individualized, comprehensive treatment of submental fat with ATX-101 according to each patient's anatomy and desired outcomes.